What is the main business of Medican Group?

The main business activity of Medican Group focuses on accounting, bookkeeping and auditing activities; tax consultancy.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 23, 2022.

Where is the headquarters located?

The headquarters is located at: Na Zakolu Wisły 12B, 30-729 Kraków.

Who is on the management board?

The management board consists of: Joanna Kycia (President of the Management Board) and Marcin Kukla (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 1,210,000 (approx. $326,850).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $37,486 in 2025, which is a decrease of 28.3% compared to 2024.

No, the company recorded a net loss of $6,850 in 2025. For comparison, in 2024 the loss was $11,908, meaning the company reduced its loss by 42.6%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $24,134 in 2025, representing 74% of all operating expenses.

Medican GroupP.S.A.

Accounting, bookkeeping and auditing activities; tax consultancy

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-11-23

Activity description

Medican Group is a contract manufacturer specializing in production and logistics services for the medical cannabis market. They provide a full range of services including processing plant-based raw materials, quality control, and the manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, all compliant with EU-GMP standards. Additionally, they facilitate the storage, distribution, and international shipping of products, ensuring regulatory compliance and product safety.

Registered address

Na Zakolu Wisły 12B/Lu2, 30-729 Kraków, Poland

Website

medicanpharm.com

Social media

Electronic delivery address

AE:PL-86839-50713-IJGBH-27

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 37.49kMedianUSD 82.47kAverageUSD 486.29k

Net profit

This companyUSD -6.85kMedianUSD 6.13kAverageUSD 42.76k

Operating costs

This companyUSD 32.42kMedianUSD 69.12kAverageUSD 424.86k

Assets

This companyUSD 966.01kMedianUSD 46.81kAverageUSD 368.32k

News

2025-12-21

Why clean air matters clinically

2025-12-21

From analysis to batch release: what EU-GMP really means

Industry

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Joanna Kycia — President of the Management Board

Marcin Kukla — Management Board Member

Manner of representation

If the management board consists of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Beneficial owners

Person	Rights
Joanna Beata Kycia (34)	Shareholder of a simple joint-stock company, 35.0%

Subsidiaries

Name	Share value	Stake
Medycyna Rzeszowskasp. z o.o.	2,701.24 USD	100%
Medycynasp. z o.o.	1,364.13 USD	75.3731%
Medycyna Serwissp. z o.o.	1,012.97 USD	75%

Competitors

	Name	Revenue	Website
	Progrupsp. z o.o.	$55,900.13	progrup.pl
	Meditaxsp. z o.o.	$9,997.49	meditax.pl

Change history

Date	Event
2023-06-15	PKD change (Added: 69.20.Z)
2023-03-07	PKD change (Removed: 69)
2022-11-23	Entered in the register

FAQ

Last updated: 2026-05-12